{"name":"Anthera Pharmaceuticals","slug":"anthera-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPUWhqLUdTNkt5RTFkZjItRDd6RnJrdlpjdDIxWS1GcWhHTUhqQVpHc1dLTVlzdlFEdUhZRXhSVTVXZUp1VkZibTEwbW1GbHdGRDZNX0xyQUxpTG9lSmxYNFdTakN4YW5Lb0w3VFlXb29oY2FyN3MxVXBYS0tQTE4xcXEzTks?oc=5","date":"2026-03-13","type":"trial","source":"Market Data Forecast","summary":"Angina Pectoris Drugs Market Size, Share & Growth, 2034 - Market Data Forecast","headline":"Angina Pectoris Drugs Market Size, Share & Growth, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gJBVV95cUxPYlJ4SUM0QW9kcmdkcGVjS2k5X2dWb3RqaTRSZGdvdEY4N3B5TVpZdGhDWXpoX1h6SnZfeU9HR0RjNzlKWWRJMUpVT09sWHVxUWdreWtYdk5zR0E4V3RTNndMNW1Wa1R6cWRRWDEyVmtoeFVZY25hdU42SDhaR2UyVERDZjNPWVBjUTMwZDUtaUVxc054NVV1c1pFZWRxYVVDWlBuaHdWSU1KUlZhcHpsdWJQNklHdW10VEhYSFlTNTNkYl9aNXRrWUJ3c0N2cDFxVVczTUJJU0Z0azNSWlVoRkx6bVMxREI1Ulp3MVBDTWN3RnAzQUlCbWpQd2xFTXlqbzNWWW9WbG01ODJEYU4wQURoMU1DQXZLQkhtbUVpVGxsdEVfY2RLSjNKUFoxeWg4dDY2Nm45SE1DODZ5TjJWMHRpNERCVTRObS1rZmVaVk04cU51dDh0akdfOXFTTlQySGc?oc=5","date":"2024-10-14","type":"pipeline","source":"globenewswire.com","summary":"Peptide Therapeutics Industry Report 2024, Featuring - globenewswire.com","headline":"Peptide Therapeutics Industry Report 2024, Featuring","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5QSnhVbkdfWnl2Ti1ua2JXY056UXJ6MmE3VDl2Y2FwZW16dHpkUFdwTFg1Yk9RWktXa2tsZzZKREYyS2hkcjF5MXlXazBzNVpublNjUENnUFlRUndERmZ6dnFXUm5DbzBlbEE?oc=5","date":"2022-11-06","type":"pipeline","source":"GuruFocus","summary":"Sanford S Zweifach Net Worth (2026) - GuruFocus","headline":"Sanford S Zweifach Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPRzlBX1NNR3RFaDhiRVYtcmFkSUlvclhzbVJhRG90cV9FeXdwazctSncwOGw5T1dINmFod0x6aFcxRU5pcE1odkJrRnA0eGVBUnBUenBobzMyOVJzRVh1N1doYzhBcjAtN1pBemFfcmtCQjZ2dVpVdllQSXhhYTM5YTNxaUhnUUQ2aFhfUWxCWUFzV2wwOUNpejIxOA?oc=5","date":"2018-06-15","type":"trial","source":"BioPharma Dive","summary":"Lilly’s Olumiant delivers positive Phase 2 lupus data - BioPharma Dive","headline":"Lilly’s Olumiant delivers positive Phase 2 lupus data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQQ3haQnlUWnQzV1gwanNPeW45YU50MG1yc0UzdGk3Yy1BX21VN3NEa3FzTmlOQmdKLWRSLVYxZTRQZ3B5c3JTVlBCem4tQl9BZXprT1dNanRjT21oR1RSRW5kRkFEUTcwbzNGTWJIWmFYRlVQcnlNcGsyR3NuU21MQ0JpamhJdw?oc=5","date":"2018-04-18","type":"pipeline","source":"BioPharma Dive","summary":"ImmuPharma dives on late-stage lupus failure - BioPharma Dive","headline":"ImmuPharma dives on late-stage lupus failure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQLWpwME9uSFlEcmoyWHNXVXV6UW1GOHMwUkprNDRwVXJDLXZOemx6eTl3WEp6dnpZUXI3MThVUEdjTEVXZllSLXhTdTJuMXZZclJrendQQ1hXdWdFcU9aX05WbzVMNVh2S25SaFpqODhJOUlVSHdMZFpzanFQTE80V2twalYwa2FnR0kwcE9LcHFrRUlFd1VBVDZGaEg?oc=5","date":"2018-03-13","type":"pipeline","source":"BioPharma Dive","summary":"Anthera shares plunge as company drops failed CF drug - BioPharma Dive","headline":"Anthera shares plunge as company drops failed CF drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPWFRyWkVlMlJEVVJCeDU0Z2x3bktXM1ZSQU5IOWM2UGlqNmxqNnNGQTFldjVONm9tNjFxS0hLYnlsTGNVN0ItSEtsNG44QjBqSW8ydXd0OTl6MVZBTjZ6SG9OODY1UHpIVktrek9JNlVGNTVRY19ZdVRLZmYyZmR0Z3hYOFBXRWQ5ai11RzE1dGIwNlRyazFN?oc=5","date":"2017-04-10","type":"trial","source":"BioPharma Dive","summary":"Clinical trial enrollment gets harder as patient populations shrink - BioPharma Dive","headline":"Clinical trial enrollment gets harder as patient populations shrink","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZ3lCT3k2N3dkVElsTnNuMTJZVFNCTTE3bEMtTExoblRyS0pTcjhVUTdyb0FvczhZQ3RQcFhoSXhucVRSR0lhMkt0aXJUM3lWSWZzQkFFRnE2cHFDdWFqMGJXQXo2NS1OZ242UkYwQ3RKcWE4VzdUNV9TVThKUXZpXzB6ZktDUHlk?oc=5","date":"2016-11-11","type":"trial","source":"BioPharma Dive","summary":"Anthera shares slump after lupus trial failure - BioPharma Dive","headline":"Anthera shares slump after lupus trial failure","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPcVAwd0V2dkhTSTN1aUMxRWR4S0IwUVBjTlRNS0MwOGtRdlhOczF6bnB1Q1N2aXdvdFhtQjZmYTRmejZvQ1JGdXBjR2NHVDFycG9vUlh0X2RpUUp3NDFOVUtZaDV4VmxtaFoydUdqX0dYdTNLcnZTNVlnQVhMOEdwak94NXFzZlgyNmJJWFIzWHRESlpac3lycDZJTXRZS05YWDVVcFRZM1hubHhGZEdFSWg4OWp6djJWRFlISzBBTURCRjhMVldtZkhiVGR1ZTViT2tNVXlYVzJMTlV6b3JWVTJobw?oc=5","date":"2015-03-24","type":"pipeline","source":"cysticfibrosisnewstoday.com","summary":"Anthera Pharmaceuticals Received $3 Million From The Cystic... - cysticfibrosisnewstoday.com","headline":"Anthera Pharmaceuticals Received $3 Million From The Cystic...","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1uN2R3LUxyenhPQjZqc0RvTmZEaVNwNmQ3dzB2UHBzVmx1NEs0RjRUcHhXcWxHZk9VcnN0NHF2MWlLRFFZY3BFTXVWa244VUNzZjZXakJubW9CU2stSHFWTVZMcTlhYTZJZ1hqUXplZG9EQQ?oc=5","date":"2014-11-28","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"30 Top VC Firms for Biotechs - Genetic Engineering and Biotechnology News","headline":"30 Top VC Firms for Biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}